Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational medication mezagitamab can effectively boost platelet counts in patients with ...
Apr 11, 2026
0
3
Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of patients within a decade.
Mar 27, 2025
0
23
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination. Researchers at Baylor College of Medicine and collaborating institutions ...
Feb 12, 2025
0
12
When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives. Yet the effectiveness of an influenza ...
Jan 2, 2025
0
70
A medical mystery served as the genesis for a Yale-led study that has promising implications for treating a range of autoimmune diseases.
Jul 16, 2024
0
228
Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment. ...
Apr 18, 2024
0
50
Recent findings at Cold Spring Harbor Laboratory (CSHL) shine a new light on pancreatic cancer.
Nov 29, 2023
0
43
Hodgkin's lymphoma is one of the most common types of lymphoma in young adults. It is characterized by the presence of enlarged B lymphocytes, which are unusual in that they bear on their surface the identifying markers of ...
Nov 8, 2023
0
40
A collaboration led by UCLA and the Seattle Children's Research Institute has yielded new knowledge about the genes responsible for the production and release of immunoglobulin G, the most common type of antibody in the human ...
Aug 14, 2023
0
57
The SARS-Cov-2 pandemic illustrates how variable vaccines can be in their length of efficacy, with regular boosters needed to keep people protected. In comparison, the immunity generated by a single vaccination against the ...
May 9, 2023
0
80
